Bimodal effects of angiotensin II on migration of human and rat smooth muscle cells: Direct stimulation and indirect inhibition via transforming growth factor-β1

Guizben Liu, Emma Espinosa, Barry S. Oemar, Thomas F. Lüscher

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Angiotensin II may be an important mediator of neointima formation in vascular disease. This study was designed to examine the mechanisms involved in angiotensin II-stimulated migration of human and rat aortic vascular smooth muscle cells (VSMCs). VSMCs were seeded in one corner of Nunc four- well culture chambers; angiotensin II within filter paper was glued onto the wall of the opposite side. After 48 hours of incubation in serum-free medium containing growth-arresting factor, migrated cells were counted using a light microscope. Angiotensin II (2 x 10-11 to 2 x 10-8 mol/L) increased migration of VSMCs in a concentration-dependent manner. Interestingly, at higher concentrations of angiotensin II (up to 2 x 10-6 mol/L) migration was reduced to levels comparable with control levels. Losartan, an AT1 receptor antagonist, prevented migration, while PD123319 an AT2 receptor antagonist, had no significant inhibitory effect. Transforming growth factor- β1 (TGF-β1; 0.01 to 10.0 pg/mL) inhibited migration induced by angiotensin II (2 x 10-8 mol/L) in a concentration-dependent manner. A neutralizing TGF-β antibody unmasked migratory effects of high concentrations of angiotensin II. Furthermore, angiotensin II (10-6 mol/L) upregulated TGF- β1 mRNA levels fivefold rat and fourfold in human VSMCs; this effect was prevented by losartan but not by PD123319. Thus, the effects of angiotensin II on migration of VSMCs are bimodal, ie, both migratory and antimigratory pathways are activated. Autocrine release of TGF-β1 induced by angiotensin II exerts an antimigratory effect in rat and human VSMCs. The AT1 receptor is involved in regulation of both pathways.

Original languageEnglish
Pages (from-to)1251-1257
Number of pages7
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume17
Issue number7
Publication statusPublished - 1997

Fingerprint

Transforming Growth Factors
Angiotensin II
Smooth Muscle Myocytes
Vascular Smooth Muscle
Losartan
Neointima
Serum-Free Culture Media
Neutralizing Antibodies
Vascular Diseases
Intercellular Signaling Peptides and Proteins
Light
Messenger RNA

Keywords

  • Angiotensin II
  • Losartan
  • Migration
  • Smooth muscle cells
  • Transforming growth factor-β1

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Bimodal effects of angiotensin II on migration of human and rat smooth muscle cells : Direct stimulation and indirect inhibition via transforming growth factor-β1. / Liu, Guizben; Espinosa, Emma; Oemar, Barry S.; Lüscher, Thomas F.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 17, No. 7, 1997, p. 1251-1257.

Research output: Contribution to journalArticle

@article{22fd4d743dbd45ba9609007d24aaceb1,
title = "Bimodal effects of angiotensin II on migration of human and rat smooth muscle cells: Direct stimulation and indirect inhibition via transforming growth factor-β1",
abstract = "Angiotensin II may be an important mediator of neointima formation in vascular disease. This study was designed to examine the mechanisms involved in angiotensin II-stimulated migration of human and rat aortic vascular smooth muscle cells (VSMCs). VSMCs were seeded in one corner of Nunc four- well culture chambers; angiotensin II within filter paper was glued onto the wall of the opposite side. After 48 hours of incubation in serum-free medium containing growth-arresting factor, migrated cells were counted using a light microscope. Angiotensin II (2 x 10-11 to 2 x 10-8 mol/L) increased migration of VSMCs in a concentration-dependent manner. Interestingly, at higher concentrations of angiotensin II (up to 2 x 10-6 mol/L) migration was reduced to levels comparable with control levels. Losartan, an AT1 receptor antagonist, prevented migration, while PD123319 an AT2 receptor antagonist, had no significant inhibitory effect. Transforming growth factor- β1 (TGF-β1; 0.01 to 10.0 pg/mL) inhibited migration induced by angiotensin II (2 x 10-8 mol/L) in a concentration-dependent manner. A neutralizing TGF-β antibody unmasked migratory effects of high concentrations of angiotensin II. Furthermore, angiotensin II (10-6 mol/L) upregulated TGF- β1 mRNA levels fivefold rat and fourfold in human VSMCs; this effect was prevented by losartan but not by PD123319. Thus, the effects of angiotensin II on migration of VSMCs are bimodal, ie, both migratory and antimigratory pathways are activated. Autocrine release of TGF-β1 induced by angiotensin II exerts an antimigratory effect in rat and human VSMCs. The AT1 receptor is involved in regulation of both pathways.",
keywords = "Angiotensin II, Losartan, Migration, Smooth muscle cells, Transforming growth factor-β1",
author = "Guizben Liu and Emma Espinosa and Oemar, {Barry S.} and L{\"u}scher, {Thomas F.}",
year = "1997",
language = "English",
volume = "17",
pages = "1251--1257",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Bimodal effects of angiotensin II on migration of human and rat smooth muscle cells

T2 - Direct stimulation and indirect inhibition via transforming growth factor-β1

AU - Liu, Guizben

AU - Espinosa, Emma

AU - Oemar, Barry S.

AU - Lüscher, Thomas F.

PY - 1997

Y1 - 1997

N2 - Angiotensin II may be an important mediator of neointima formation in vascular disease. This study was designed to examine the mechanisms involved in angiotensin II-stimulated migration of human and rat aortic vascular smooth muscle cells (VSMCs). VSMCs were seeded in one corner of Nunc four- well culture chambers; angiotensin II within filter paper was glued onto the wall of the opposite side. After 48 hours of incubation in serum-free medium containing growth-arresting factor, migrated cells were counted using a light microscope. Angiotensin II (2 x 10-11 to 2 x 10-8 mol/L) increased migration of VSMCs in a concentration-dependent manner. Interestingly, at higher concentrations of angiotensin II (up to 2 x 10-6 mol/L) migration was reduced to levels comparable with control levels. Losartan, an AT1 receptor antagonist, prevented migration, while PD123319 an AT2 receptor antagonist, had no significant inhibitory effect. Transforming growth factor- β1 (TGF-β1; 0.01 to 10.0 pg/mL) inhibited migration induced by angiotensin II (2 x 10-8 mol/L) in a concentration-dependent manner. A neutralizing TGF-β antibody unmasked migratory effects of high concentrations of angiotensin II. Furthermore, angiotensin II (10-6 mol/L) upregulated TGF- β1 mRNA levels fivefold rat and fourfold in human VSMCs; this effect was prevented by losartan but not by PD123319. Thus, the effects of angiotensin II on migration of VSMCs are bimodal, ie, both migratory and antimigratory pathways are activated. Autocrine release of TGF-β1 induced by angiotensin II exerts an antimigratory effect in rat and human VSMCs. The AT1 receptor is involved in regulation of both pathways.

AB - Angiotensin II may be an important mediator of neointima formation in vascular disease. This study was designed to examine the mechanisms involved in angiotensin II-stimulated migration of human and rat aortic vascular smooth muscle cells (VSMCs). VSMCs were seeded in one corner of Nunc four- well culture chambers; angiotensin II within filter paper was glued onto the wall of the opposite side. After 48 hours of incubation in serum-free medium containing growth-arresting factor, migrated cells were counted using a light microscope. Angiotensin II (2 x 10-11 to 2 x 10-8 mol/L) increased migration of VSMCs in a concentration-dependent manner. Interestingly, at higher concentrations of angiotensin II (up to 2 x 10-6 mol/L) migration was reduced to levels comparable with control levels. Losartan, an AT1 receptor antagonist, prevented migration, while PD123319 an AT2 receptor antagonist, had no significant inhibitory effect. Transforming growth factor- β1 (TGF-β1; 0.01 to 10.0 pg/mL) inhibited migration induced by angiotensin II (2 x 10-8 mol/L) in a concentration-dependent manner. A neutralizing TGF-β antibody unmasked migratory effects of high concentrations of angiotensin II. Furthermore, angiotensin II (10-6 mol/L) upregulated TGF- β1 mRNA levels fivefold rat and fourfold in human VSMCs; this effect was prevented by losartan but not by PD123319. Thus, the effects of angiotensin II on migration of VSMCs are bimodal, ie, both migratory and antimigratory pathways are activated. Autocrine release of TGF-β1 induced by angiotensin II exerts an antimigratory effect in rat and human VSMCs. The AT1 receptor is involved in regulation of both pathways.

KW - Angiotensin II

KW - Losartan

KW - Migration

KW - Smooth muscle cells

KW - Transforming growth factor-β1

UR - http://www.scopus.com/inward/record.url?scp=0030755733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030755733&partnerID=8YFLogxK

M3 - Article

C2 - 9261254

AN - SCOPUS:0030755733

VL - 17

SP - 1251

EP - 1257

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 7

ER -